F Baquero Selected Research

F Baquero Research Topics

10	Infections 08/2018 - 01/2000
4	Respiratory Tract Infections (Respiratory Tract Infection) 01/2002 - 01/2000
2	Community-Acquired Infections 11/2008 - 01/2008
2	Communicable Diseases (Infectious Diseases) 12/2006 - 12/2002
2	Bacterial Infections (Bacterial Infection) 06/2003 - 01/2002
1	Cytomegalovirus Infections (Inclusion Disease) 08/2018
1	Cysts 08/2018
1	Osteomyelitis 07/2011
1	Pneumonia (Pneumonitis) 04/2008
1	Enterobacteriaceae Infections 11/2007
1	Tuberculosis (Tuberculoses) 07/2006
1	Wounds and Injuries (Trauma) 06/2006
1	Intraabdominal Infections 03/2006
1	Cystic Fibrosis (Mucoviscidosis) 09/2005
1	Lung Diseases (Lung Disease) 09/2005
1	Acquired Immunodeficiency Syndrome (AIDS) 02/2002
1	Chronic Bronchitis 01/2002
1	Bacterial Pneumonia 01/2002
1	Sepsis (Septicemia) 02/2001
1	Abscess 11/2000
1	Hepatitis E 04/2000
1	Cross Infection (Nosocomial Infection) 01/2000

9	Anti-Bacterial Agents (Antibiotics)IBA 05/2016 - 01/2000
3	Cephalosporins (Cephalosporin Antibiotics)IBA 11/2000 - 01/2000
2	EnzymesIBA 11/2008 - 01/2008
2	beta-Lactamases (beta-Lactamase)IBA 03/2006 - 02/2001
2	Anti-Infective Agents (Microbicides)IBA 09/2005 - 03/2000
2	Cefotaxime (Kendrick)FDA LinkGeneric 02/2001 - 11/2000
1	cytomegalovirus-specific hyperimmune globulinIBA 08/2018
1	Immunoglobulins (Immunoglobulin)IBA 08/2018
1	Methicillin (Metin)FDA Link 07/2011
1	VIM-1 metallo-beta-lactamaseIBA 11/2007
1	Linezolid (Zyvox)FDA Link 07/2006
1	Colistin (Coly-Mycin)FDA Link 09/2005
1	Ciprofloxacin (Cipro)FDA LinkGeneric 09/2005
1	Tobramycin (Nebcin)FDA LinkGeneric 09/2005
1	Ertapenem (Invanz)FDA Link 06/2003
1	Erythromycin (Erycette)FDA LinkGeneric 09/2001
1	telithromycin (Ketek)FDA Link 09/2001
1	Ceftazidime (Fortum)FDA LinkGeneric 02/2001
1	Amoxicillin (Wymox)FDA LinkGeneric 11/2000
1	Penicillins (Penicillin)FDA Link 11/2000
1	AntibodiesIBA 04/2000
1	avoparcinIBA 03/2000
1	Moxifloxacin (Avelox)FDA Link 03/2000
1	Third Generation CephalosporinsIBA 01/2000
1	AminoglycosidesIBA 01/2000